The impact of the state of Georgia's only public medical school spans from its founding
nearly 200 years ago, in 1828, as one of the nation's first medical schools to its
current role optimizing health and health care in Georgia and beyond through education,
discovery and service.
The Medical College of Georgia is one of the nation’s largest medical schools by class size, with 260 students per
class. The educational experience is anchored by the main campus in Augusta, regional clinical campuses for third- and fourth-year students across the state and a second four-year campus
in Athens in partnership with the University of Georgia. MCG’s expanding partnerships
with physicians and hospitals across Georgia currently provides about 350 sites where
students can experience the full spectrum of medicine, from complex care hospitals
to small-town solo practices. MCG and its teaching hospitals also provide postgraduate
education to more than 500 residents and fellows in 50 different Accreditation Council
for Graduate Medical Education-approved programs.
Our researchers and clinicians focus on what most impacts the health of Georgia's
and America’s children and adults, including cardiovascular biology and disease, cancer,
neurosciences and behavioral sciences, public and preventive health, regenerative
reparative medicine, personalized medicine and genomics. Our physician faculty also
share their expertise with physicians and patients at
about 100 clinics and hospitals statewide.
Medical College of Georgia News
TDAExplore takes the detailed imaging provided by microscopy, pairs it with a hot area of mathematics called topology and the analytical power of artificial intelligence to give a new perspective on changes in a cell and where they happen, says Dr. Eric Vitriol, cell biologist and neuroscientist at the Medical College of Georgia.
The interaction of a natural lock and key recruits immune cells to the pancreas, which attack insulin-producing islet cells, resulting in a lifelong course of insulin therapy and a lifelong increased risk of other health problems like heart and kidney disease
MCG scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals, can safely reduce oxidative stress and inflammation in the retina.
She chaired the society’s Public Relations Committee from 2016-19 and its Membership Committee from 2019-20.
MORE MCG NEWS COVID-19 INFORMATION MCG PANDEMIC MEDICAL EDUCATION CLUB ON YOUTUBE
Tailor-made medical education